We are live on ! Find out more
CABA icon

Cabaletta Bio
CABA

84 hedge funds and large institutions have $470M invested in Cabaletta Bio in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $1.43M | Put options by funds: $529K

131% more capital invested

Capital invested by funds: $204M → $470M (+$267M)

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

18% more funds holding

Funds holding: 71 → 84 (+13)

13.19% more ownership

Funds ownership: 78.62% → 91.81% (+13%)

Holders
84
Holders Change
+13
Holders Change %
+18.31%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
29
Increased
29
Reduced
13
Closed
16
Calls
$1.43M
Puts
$529K
Net Calls
+$904K
Net Calls Change
+$224K

Top Buyers

Rank Fund Capital Flow
1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$21.7M
2
DM
Deerfield Management
New York
+$20.4M
3
BlackRock
BlackRock
New York
+$16M
4
RG
Redmile Group
California
+$11.9M
5
Invesco
Invesco
Georgia
+$9.3M

Top Sellers

Rank Fund Capital Flow
1
LCM
Lynx1 Capital Management
Puerto Rico
-$2.97M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.88M
3
Marshall Wace
Marshall Wace
United Kingdom
-$2.64M
4
Millennium Management
Millennium Management
New York
-$2.18M
5
BCM
Bridgeway Capital Management
Texas
-$1.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
76
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.39K – – –
FDCC
77
Foster Dykema Cabot & Co
Massachusetts
$4K +$3.35K +309 New
Federated Hermes
78
Federated Hermes
Pennsylvania
$3.52K +$2.96K +273 New
IPW
79
Impact Partnership Wealth
Georgia
$3.52K +$2.96K +273 New
Fidelity Investments
80
Fidelity Investments
Massachusetts
$3.06K +$2.42K +223 +1,593%
BHWM
81
Beaird Harris Wealth Management
Texas
$1.02K – – –
CAL
82
Capital Advisors Ltd
Ohio
$1K – – –
BWL
83
Bogart Wealth LLC
Virginia
$646 – – –
NC
84
NewSquare Capital
Pennsylvania
$129 – – –
Susquehanna International Group
85
Susquehanna International Group
Pennsylvania
– -$2.88M -265,355 Closed
Goldman Sachs
86
Goldman Sachs
New York
– -$1.34M -161,596 Closed
Jane Street
87
Jane Street
New York
– -$858K -103,791 Closed
HF
88
HRT Financial
New York
– -$828K -100,224 Closed
CC
89
Caxton Corporation
New Jersey
– -$336K -40,581 Closed
CSS
90
Cubist Systematic Strategies
Connecticut
– -$301K -36,457 Closed
Citadel Advisors
91
Citadel Advisors
Florida
– -$230K -21,197 Closed
6CM
92
683 Capital Management
New York
– -$141K -17,000 Closed
CAM
93
Concorde Asset Management
Michigan
– -$131K -15,800 Closed
LP
94
LMR Partners
United Kingdom
– -$111K -13,422 Closed
BFM
95
Boothbay Fund Management
New York
– -$104K -12,528 Closed
DC
96
Diametric Capital
Massachusetts
– -$90.7K -10,966 Closed
TI
97
Trexquant Investment
Connecticut
– -$86.9K -10,511 Closed
Point72 Asset Management
98
Point72 Asset Management
Connecticut
– -$43.4K -5,243 Closed
PMEF
99
Point72 Middle East FZE
United Arab Emirates
– -$30.9K -3,742 Closed
DA
100
Denali Advisors
California
– -$11.6K -1,400 Closed
1 2 3
4

CABA Hedge Fund Activity: Q2 2023 in Review

84 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q2 2023, worth a combined $470M — up 131% from $204M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new CABA positions and 16 closed out — a net gain of 13 holders — while 29 added to existing stakes and 13 trimmed.

The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $21.7M. The largest seller was Lynx1 Capital Management, cutting an estimated $2.97M.

  • 84 institutional investors held Cabaletta Bio (CABA) as of Q2 2023, up from 71 in Q1 2023.
  • Funds reported $470M of Cabaletta Bio stock for Q2 2023, up 131% quarter-over-quarter.
  • 29 funds opened new Cabaletta Bio positions in Q2 2023 and 16 closed out, a net change of +13 holders.
  • The largest Cabaletta Bio buyer in Q2 2023 was Bain Capital Life Sciences Investors, an estimated $21.7M added.
  • The largest Cabaletta Bio seller in Q2 2023 was Lynx1 Capital Management, an estimated $2.97M sold.

Based on aggregated 13F filings for Q2 2023.